Analysis of blood-based gene expression in idiopathic Parkinson disease
暂无分享,去创建一个
G. Deuschl | R. Shamir | I. Ulitsky | Ofer Lavi | D. Krainc | A. Brice | S. Lesage | J. Corvol | S. Poths | O. Riess | M. Bonin | H. Safer | B. Peterlin | C. Klein | A. Maver | D. Amar | Y. Wong | M. Kasten | E. Vollstedt | M. Usenovic | G. Kuhlenbaeumer | H. Pawlack
[1] Jose A. Santiago,et al. Biosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients , 2012, PloS one.
[2] R. Lencer,et al. Depression and quality of life in monogenic compared to idiopathic, early‐onset Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[3] Jose A. Santiago,et al. Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson’s disease , 2015, Proceedings of the National Academy of Sciences.
[4] P. Riederer,et al. Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson’s disease , 2010, Journal of Neural Transmission.
[5] Manuel B. Graeber,et al. PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease , 2010, Science Translational Medicine.
[6] David M. Simcha,et al. Tackling the widespread and critical impact of batch effects in high-throughput data , 2010, Nature Reviews Genetics.
[7] L. Petrucelli,et al. A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease. , 2009, Biochimica et biophysica acta.
[8] Hagai Bergman,et al. Advanced microarray analysis highlights modified neuro-immune signaling in nucleated blood cells from Parkinson's disease patients , 2008, Journal of Neuroimmunology.
[9] S. Mandel,et al. A molecular signature in blood identifies early Parkinson’s disease , 2012, Molecular Neurodegeneration.
[10] D. di Bernardo,et al. Blood transcriptomics of drug-naïve sporadic Parkinson’s disease patients , 2015, BMC Genomics.
[11] Hagai Bergman,et al. Exon Arrays Reveal Alternative Splicing Aberrations in Parkinson’s Disease Leukocytes , 2011, Neurodegenerative Diseases.
[12] Hagai Bergman,et al. Long Non-Coding RNA and Alternative Splicing Modulations in Parkinson's Leukocytes Identified by RNA Sequencing , 2014, PLoS Comput. Biol..
[13] David Venet,et al. Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome , 2011, PLoS Comput. Biol..
[14] S. Minoshima,et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.
[15] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[16] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[17] H. Siebner,et al. Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[18] J. Trempe,et al. Structure and Function of Parkin, PINK1, and DJ-1, the Three Musketeers of Neuroprotection , 2013, Front. Neurol..
[19] Gary D. Bader,et al. GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop , 2010, Bioinform..
[20] L. Ein-Dor,et al. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[21] J. Growdon,et al. Molecular markers of early Parkinson's disease based on gene expression in blood , 2007, Proceedings of the National Academy of Sciences.
[22] O. Troyanskaya,et al. Low‐variance RNAs identify Parkinson's disease molecular signature in blood , 2015, Movement disorders : official journal of the Movement Disorder Society.
[23] A. Chen-Plotkin. Unbiased Approaches to Biomarker Discovery in Neurodegenerative Diseases , 2014, Neuron.
[24] R. Sharan,et al. Expander: from expression microarrays to networks and functions , 2010, Nature Protocols.
[25] J. Vance,et al. SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's Disease , 2010, PloS one.
[26] William T. Hu,et al. Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease , 2011, Annals of neurology.
[27] T. Montine,et al. Plasma apolipoprotein A1 as a biomarker for Parkinson disease , 2013, Annals of neurology.
[28] Lama M Chahine,et al. Blood-based biomarkers for Parkinson's disease. , 2014, Parkinsonism & related disorders.
[29] Andrew E. Jaffe,et al. Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .
[30] Jose A. Santiago,et al. Current Challenges Towards the Development of a Blood Test for Parkinson’s Disease , 2014, Diagnostics.
[31] A. Vashisht,et al. Voltage-dependent Anion Channels (VDACs) Recruit Parkin to Defective Mitochondria to Promote Mitochondrial Autophagy* , 2012, The Journal of Biological Chemistry.
[32] L. Defebvre,et al. Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation , 2011, Neurobiology of Aging.
[33] Nir Giladi,et al. Decreased expression of B cell related genes in leukocytes of women with Parkinson's disease , 2011, Molecular Neurodegeneration.
[34] Zheng Guo,et al. Extracting a few functionally reproducible biomarkers to build robust subnetwork-based classifiers for the diagnosis of cancer. , 2013, Gene.
[35] M. Toft,et al. Found in transcription: accurate Parkinson's disease classification in peripheral blood. , 2013, Journal of Parkinson's disease.